Test Price
2,800 AED✅ Home Collection Available
DTNA Gene Left Ventricular Noncompaction 1 (LVNC1) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Precision & Service Guarantees
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via NGS processed in an ISO 9001:2015 certified laboratory.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance and genetic counselling to interpret results.
- Data Privacy: Strict adherence to Federal Decree-Law No. 45 of 2021 (PDPL) for all genetic data processing and storage.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The DTNA gene NGS test detects pathogenic variants linked to left ventricular noncompaction (LVNC) and congenital heart defects, aiding in diagnosis, family screening, and personalized management. This comprehensive analysis leverages next-generation sequencing to provide reliable results for guiding cardiac care and risk stratification.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Technology | Next Generation Sequencing (Illumina®) | Sanger Sequencing |
| Analytical Sensitivity | >99.9% for SNVs, indels & CNVs | ~99% (limited to targeted region) |
| Turnaround Time | 14-18 Business Days | 10-15 Business Days |
| Genomic Coverage | Full coding exons ± 20 bp intronic boundaries | Single exon coverage |
| Clinical Utility | Comprehensive – LVNC, CHD, genotype-phenotype correlation | Limited; may miss deep intronic or large rearrangements |
Physician Insight & Safety Protocols
“Genetic testing for a cardiac condition such as LVNC can bring profound clarity for your diagnosis and family planning. This DTNA analysis is a powerful tool, yet it must be interpreted alongside your echocardiogram, clinical history, and a comprehensive pedigree analysis by a certified genetic counselor. Our multidisciplinary team is committed to supporting you through every step, from pre-test counseling to post-result management.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Safety Protocols & Exclusion Criteria
Important Safety Information
- Exclusion: Recent whole blood transfusion (<4 weeks) due to donor DNA interference.
- Exclusion: Known interfering medication or chemo/radiotherapy affecting DNA quality.
- Medication Warning: Do not discontinue any prescribed cardiac medication (e.g., beta-blockers, ACE inhibitors) without consulting your treating physician.
- ER Red Flags: Sudden severe chest pain, loss of consciousness (syncope), racing heart with dizziness — proceed to nearest emergency department immediately.
- Minors: Genetic testing for children requires informed consent from a legal guardian, compliant with UAE Federal Law.
Patient FAQ & Clinical Guidance
1. What is the DTNA gene test used for?
The DTNA genetic test identifies pathogenic variants causing left ventricular noncompaction and associated congenital heart defects to guide diagnosis and family screening.
2. How is the sample collected?
A simple blood draw or dried blood spot card is collected at home by a licensed phlebotomist with cold-chain transport to maintain DNA integrity.
3. What does a positive result mean?
A positive result indicates a disease-causing variant in the DTNA gene that confirms diagnosis and allows cascade testing, but does not predict severity.
UAE Regulatory & Data Privacy Adherence
Legal Mandates: This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols align with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is stored and processed on secure servers within the UAE with encrypted access.
Accreditation: Laboratory certified ISO 9001:2015. DHA Facility License: 1143. Testing methodology aligns with CAP/CLIA standards.
Clinical & Logistical Metadata
| Test Name | DTNA Gene Left Ventricular Noncompaction 1 (LVNC1) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 14-18 Business Days |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) |
| Methodology Used | Next Generation Sequencing (NGS) - Illumina® Platform |
| ICD-10-CM Code | I42.8 (Cardiomyopathy), Q24.9 (CHD) |
| LOINC Code | 51966-3 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians